Rentokil Initial (NYSE:RTO) Shares Gap Up to $30.48

Rentokil Initial plc (NYSE:RTOGet Rating)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $30.48, but opened at $33.08. Rentokil Initial shares last traded at $33.25, with a volume of 127,651 shares.

Analyst Ratings Changes

Separately, Barclays began coverage on Rentokil Initial in a research report on Tuesday, March 7th. They set an “overweight” rating on the stock.

Rentokil Initial Stock Down 1.4 %

The stock has a 50-day moving average of $30.96.

Hedge Funds Weigh In On Rentokil Initial

A number of institutional investors have recently made changes to their positions in RTO. Parallel Advisors LLC acquired a new position in shares of Rentokil Initial in the 4th quarter valued at approximately $26,000. Delta Asset Management LLC TN acquired a new position in shares of Rentokil Initial in the 4th quarter valued at approximately $27,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Rentokil Initial in the 4th quarter valued at approximately $32,000. Lindbrook Capital LLC acquired a new position in shares of Rentokil Initial in the 4th quarter valued at approximately $34,000. Finally, Ellevest Inc. acquired a new position in shares of Rentokil Initial in the 4th quarter valued at approximately $36,000. 0.41% of the stock is owned by institutional investors and hedge funds.

About Rentokil Initial

(Get Rating)

Rentokil Initial Plc engages in the provision of business support services. Its products and services protect people from the pest-borne disease and the risks of poor hygiene. It operates through the following geographical segments: France, Benelux, Germany, Southern Europe, and Latin America. The firm focuses on route-based services, predominately in pest control and hygiene as well as other smaller services including plants, medical, property care.

See Also

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.